Skip to main content
Premium Trial:

Request an Annual Quote

Hackers Target Biotechs

Hackers have been targeting the emails of publicly traded health care or pharmaceutical company employees for more than a year, trying to obtain information, such as clinical trial news, that could affect global markets, the New York Times reports.

The security firm reporting the breach, FireEye, didn't disclose the affected firms, but said half of them are in the biotechnology sector. Additionally, FireEye said these hackers appeared to represent "a new breed," according to the Times.

"Their email lures are precisely tailored toward each victim, written in flawless English and carefully worded to sound as if they were sent by someone with an extensive background in investment banking and with knowledge of the terms those in the industry employ," the Times says.

Some executives, it adds, have been drawn in and clicked on links or opened attachments to those emails, and were redirected to a fake email login site designed to steal their information. This way, the attackers could read their victim's email.

"Given the types of people they are targeting, they don't need to go into the environment; the senior roles they target have enough juicy information in their inbox," Jen Weedon, a FireEye threat intelligence manager, tells the Times. "They are after information protected by attorney-client privilege, safety reports, internal documents about investigations, and audits."

Filed under

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.